Emma G Wilmot (E G Wilmot)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Topics

Clinical Practice

Cross Sectional

Cardiovascular Disease

Top Venues

Diabetes, obesity & metabolism

Diabetic medicine : a journal of the British Diabetic Association

Endocrine reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandros Leonidas Liarakos, Jonathan Z M Lim, Lalantha Leelarathna, Emma G Wilmot
The use of technology in type 2 diabetes and prediabetes: a narrative review. Diabetologia (2024)
Alexandros Leonidas Liarakos, Thomas S J Crabtree, Emma G Wilmot
Patient-reported outcomes in studies of diabetes technology: What matters. Diabetes, obesity & metabolism (2024)
Rachel Ann Elliott, Gabriel Rogers, Mark L Evans, Sankalpa Neupane, Gerry Rayman, Sarah Lumley, Iain Cranston, Parth Narendran, Christopher J Sutton, Vicky P Taxiarchi, Matthew Burns, Hood Thabit, Emma G Wilmot, Lalantha Leelarathna, null null
Estimating the cost effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in England. Diabetic medicine : a journal of the British Diabetic Association (2023)
John S Pemberton, Emma G Wilmot, Katharine Barnard-Kelly, Lalantha Leelarathna, Nick Oliver, Tabitha Randell, Craig E Taplin, Pratik Choudhary, Peter Adolfsson
CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review. Diabetes, obesity & metabolism 25 (4) (2023)
John S Pemberton, Emma G Wilmot, Katharine Barnard-Kelly, Lalantha Leelarathna, Nick Oliver, Tabitha Randell, Craig E Taplin, Pratik Choudhary, Peter Adolfsson
CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review. Diabetes, obesity & metabolism 25 (4) (2023)
John S Pemberton, Emma G Wilmot, Katharine Barnard-Kelly, Lalantha Leelarathna, Nick Oliver, Tabitha Randell, Craig E Taplin, Pratik Choudhary, Peter Adolfsson
CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review. Diabetes, obesity & metabolism 25 (4) (2023)
Charlotte Mark-Wagstaff, Harshal Deshmukh, Emma G Wilmot, Neil Walker, Dennis Barnes, Vernon Parfitt, Simon Saunders, Rob Gregory, Pratik Choudhary, Jane Patmore, Chris Walton, Robert E J Ryder, Thozhukat Sathyapalan
Intermittently scanned continuous glucose monitoring and hypoglycaemia awareness in drivers with diabetes: Insights from the Association of British Clinical Diabetologists Nationwide audit. Diabetes, obesity & metabolism (2023)
Kamlesh Khunti F MedSci, Yuehuan Chung, Jim Davies, Benjamin C T Field, Sophie Harris, Mikhail Naum Kosiborod, Dinesh Nagi, Parth Narendran, Dipesh Patel, Robert E J Ryder, Kinga A Várnai, Sarah D Wild, Emma G Wilmot, Rustam D Rea, null null
Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19. Diabetes care (2022)
John S Pemberton, Emma G Wilmot, Katharine Barnard-Kelly, Lalantha Leelarathna, Nick Oliver, Tabitha Randell, Craig E Taplin, Pratik Choudhary, Peter Adolfsson
CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA) - A narrative review. Diabetes, obesity & metabolism (2022)
John S Pemberton, Emma G Wilmot, Katharine Barnard-Kelly, Lalantha Leelarathna, Nick Oliver, Tabitha Randell, Craig E Taplin, Pratik Choudhary, Peter Adolfsson
CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review. Diabetes, obesity & metabolism (2022)
Moshe Phillip, Revital Nimri, Richard M Bergenstal, Katharine D Barnard-Kelly, Thomas Danne, Roman Hovorka, Boris P Kovatchev, Laurel H Messer, Christopher G Parkin, Louise Ambler-Osborn, Stephanie A Amiel, Lia Bally, Roy W Beck, Sarah Biester, Torben Biester, Julia E Blanchette, Emanuele Bosi, Charlotte K Boughton, Marc D Breton, Sue A Brown, Bruce A Buckingham, Albert Cai, Anders L Carlson, Jessica R Castle, Pratik Choudhary, Kelly L Close, Claudio Cobelli, Amy B Criego, Elizabeth A Davis, Carine de Beaufort, Martin I de Bock, Daniel J DeSalvo, J Hans DeVries, Klemen Dovc, Francis J Doyle, Laya Ekhlaspour, Naama Fisch Shvalb, Gregory P Forlenza, Geraldine Gallen, Satish K Garg, Dana C Gershenoff, Linda A Gonder-Frederick, Ahmad Haidar, Sara Hartnell, Lutz Heinemann, Simon Heller, Irl B Hirsch, Korey K Hood, Diana Isaacs, David C Klonoff, Olga Kordonouri, Aaron Kowalski, Lori M B Laffel, Julia Lawton, Rayhan A Lal, Lalantha Leelarathna, David M Maahs, Helen R Murphy, Kirsten Nørgaard, David O'Neal, Sean M Oser, Tamara K Oser, Pr Eric Renard, Michael C Riddell, David Rodbard, Steven J Russell, Desmond A Schatz, Viral N Shah, Jennifer L Sherr, Gregg D Simonson, R Paul Wadwa, Candice Ward, Stuart A Weinzimer, Emma G Wilmot, Tadej Battelino
Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice. Endocrine reviews (2022)
Robert Blissett, Deirdre B Blissett, Fleur Levrat-Guillen, Harshal Deshmukh, Emma G Wilmot, Robert E J Ryder, Chris Walton, Thozhukat Sathyapalan
FreeStyle Libre Flash Glucose Monitoring system for people with type 1 diabetes in the UK: a budget impact analysis. BMJ open diabetes research & care 10 (2) (2022)
Othmar Moser, Michael C Riddell, Max L Eckstein, Peter Adolfsson, Remi Rabasa-Lhoret, Louisa van den Boom, Pieter Gillard, Kirsten Nørgaard, Nicholas S Oliver, Dessi P Zaharieva, Tadej Battelino, Carine de Beaufort, Richard M Bergenstal, Bruce A Buckingham, Eda Cengiz, Asma Deeb, Tim Heise, Simon R Heller, Aaron J Kowalski, Lalantha Leelarathna, Chantal Mathieu, Christoph Stettler, Martin Tauschmann, Hood Thabit, Emma G Wilmot, Harald Sourij, Carmel E M Smart, Peter G Jacobs, Richard M Bracken, Julia Katharina Mader
Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). Diabetologia 63 (12) (2021)
Hannah Forde, Emma G Wilmot, Pratik Choudhary
Letter to the editor. Diabetic medicine : a journal of the British Diabetic Association 38 (7) (2021)
Othmar Moser, Michael C Riddell, Max L Eckstein, Peter Adolfsson, Remi Rabasa-Lhoret, Louisa van den Boom, Pieter Gillard, Kirsten Nørgaard, Nicholas S Oliver, Dessi P Zaharieva, Tadej Battelino, Carine de Beaufort, Richard M Bergenstal, Bruce A Buckingham, Eda Cengiz, Asma Deeb, Tim Heise, Simon R Heller, Aaron J Kowalski, Lalantha Leelarathna, Chantal Mathieu, Christoph Stettler, Martin Tauschmann, Hood Thabit, Emma G Wilmot, Harald Sourij, Carmel E M Smart, Peter G Jacobs, Richard M Bracken, Julia Katharina Mader
Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations? Reply to Yardley JE and Sigal RJ [letter]. Diabetologia 64 (4) (2021)
Emma G Wilmot, Kelly L Close, Dubravka Jurišić-Eržen, Daniela Bruttomesso, Francisco Javier Ampudia-Blasco, Zsolt Bosnyak, Aude Roborel de Climens, Grégory Bigot, Anne L Peters, Eric Renard, Lori D Berard, Luis Eduardo Calliari, Jochen Seufert
Patient-reported outcomes in adults with type 1 diabetes in global real-world clinical practice: The SAGE study. Diabetes, obesity & metabolism 23 (8) (2021)
Emma G Wilmot, Mark Evans, Katharine D Barnard-Kelly, M Burns, Iain Cranston, Rachel Ann Elliott, G Gkountouras, N Kanumilli, A Krishan, C Kotonya, S Lumley, P Narendran, Sankalpa Neupane, Gerry Rayman, Christopher Sutton, V P Taxiarchi, H Thabit, L Leelarathna
Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol. BMJ open 11 (7) (2021)
Pratik Choudhary, Emma G Wilmot, Karissa Owen, Dipesh C Patel, Lesley Mills, Gerry Rayman, Peter Winocour, Goher Ayman, Rohit Patel, Clare Hambling, Dinesh K Nagi
A roadmap to recovery: ABCD recommendations on risk stratification of adult patients with diabetes in the post-COVID-19 era. Diabetic medicine : a journal of the British Diabetic Association 38 (3) (2020)
David Martin Shaw, Thomas S J Crabtree, P Hammond, A McLay, Emma G Wilmot
The DIY artificial pancreas system: an ethical dilemma for doctors. Diabetic medicine : a journal of the British Diabetic Association 37 (11) (2020)
L Dowling, Emma G Wilmot, Pratik Choudhary
Do-it-yourself closed-loop systems for people living with type 1 diabetes. Diabetic medicine : a journal of the British Diabetic Association 37 (12) (2020)
Emma G Wilmot, Alistair Lumb, P Hammond, Helen R Murphy, E Scott, Fraser W Gibb, J Platts, Pratik Choudhary
Time in range: A best practice guide for UK diabetes healthcare professionals in the context of the COVID-19 global pandemic. Diabetic medicine : a journal of the British Diabetic Association 38 (1) (2020)
Lalantha Leelarathna, Pratik Choudhary, Emma G Wilmot, Alistair Lumb, Tim Street, Partha Kar, Sze May Ng
Hybrid closed-loop therapy: Where are we in 2021? Diabetes, obesity & metabolism 23 (3) (2020)
Stephen C Bain, M Feher, M Fisher, Nick Hex, K C S Lee, J Mahon, D Russell-Jones, H Schou, Emma G Wilmot, M Baxter
A review of the NG17 recommendations for the use of basal insulin in type 1 diabetes. Diabetic medicine : a journal of the British Diabetic Association 37 (2) (2019)
Emma G Wilmot, Pratik Choudhary, Lalantha Leelarathna, Mike Baxter
Glycaemic variability: The under-recognized therapeutic target in type 1 diabetes care. Diabetes, obesity & metabolism 21 (12) (2019)